Shubha Allard MD FRCP FRCPath, Consultant Haematologist, NHS Blood and Transplant. Clinical Director for NHSBT Patient Blood Management Consultants Team and Secretary National Blood Transfusion Committee.  Actively promoting Patient Blood Management together with key activities needed to support safe clinical and laboratory transfusion practice including guidelines and implementation, clinical audit, education and training together with steering national policies. As current RCPath Clinical Director for Publishing & Engagement actively promoting the role and expertise of various pathology specialities in patient care together with wider public awareness.

Peter Collins is a professor in haematology at the School of Medicine of Cardiff University and an honorary consultant haematologist at the Cardiff Haemophilia Centre. He is vice chair of the UK Haemophilia Centre Doctors’ Organisation and chairs the Data Management Working Party of the UK National Haemophillia Database. 

His clinical research interests include acquired haemophilia, prophylactic treatment of haemophilia, factor VIII inhibitors, pharmacokinetics of factor VIII and IX, haemostatic impairment during postpartum haemorrhage. Basic science interests are the role of phospholipids in controlling coagulation and interactions between coagulation and complement. 

Lise Estcourt is a Consultant Haematologist for NHS Blood and Transplant, and Senior Clinical Lecturer in Transfusion Medicine. Her research in transfusion medicine focuses on the safe and appropriate use of blood components and their alternatives. Her research work involves systematic reviews (Cochrane and non-Cochrane); clinical trials; and clinical studies. She works with several other organisations to improve health and healthcare. She is the Clinical Lead for the National Comparative Audit in Blood Transfusion, Director of NHSBT Clinical Trials Unit and Clinical Tutor for NHSBT. She is the co-ordinating editor of Cochrane Haematological Malignancies and an editor of the journal Transfusion Medicine.”

Dr Sharran Grey is a Consultant Clinical Scientist in the Clinical Haematology Department at the Lancashire Haematology Centre: a tertiary haematology service serving Lancashire and South Cumbria. In addition to her clinical work, her responsibilities are consultant lead for haematology and transfusion laboratories across Blackpool and Preston, and consultant lead for Clinical Blood Transfusion. She is also the working expert for Transfusion-Associated Circulatory Overload with SHOT, and contributes to the writing of guidelines and papers at a national and international level.

Professor of Thrombosis & Haemostasis at King’s College London; 
Consultant in the Departments of Haematology & Pathology at Guy’s & St Thomas NHS Foundation Trust; & Clinical Lead in Haematological Sciences at Viapath LLP

Clinical & laboratory
She has a large clinical practice, specialising in thrombosis and haemostasis & obstetric haematology. She leads on the management of thrombosis within GSTT. She set up the GSTT award-winning “Thrombosis” app – thrombosis management in elegant algorithms
Her laboratory work includes sitting on the board of Viapath LLP and leading in all aspects of haematological laboratory work. 

Research & Development
She runs a research group with over 360 peer-reviewed publications to her name, and won the BMJ Research paper of the year 2011 with the CRASH-2 team.  
She led on behalf of the UK thrombosis and haemostasis community in a successful bid to bring the ISTH meeting (10-12,000 delegates) to the Excel Centre, London in 2022 
She was awarded an OBE in the Queen’s birthday honours list in 2019 for services to medicine
In the COVID-19 pandemic she has become an international expert on thrombosis and coagulopathy in COVID-19 patients, and has given numerous webinars including being an expert witness for the British House of Lords Science and Technology Committee. She has also given numerous media interviews including working with BBC News.
 

Dr Banu Kaya is a consultant haematologist at Barts Health NHS Trust, London and honorary Clinical Senior Lecturer, Barts and The London School of Medicine and Dentistry, Queen Mary University of London. 

Dr Kaya led the paediatric component of the National Haemoglobinopathy Peer Review Programme and co-chaired the steering group, 2014-2016. She was appointed to the haemoglobinopathies Clinical Reference Group in 2019 and jointly leads the regional Haemoglobinopathy Coordinating Centre. She is a Trustee of the British Society of Haematology. 

Dr Kaya has been the UK Chief Investigator for a number of international clinical trials and has contributed to a number of recent national guidelines. 
 

I am a Haematology ST6 Registrar and have undertaken my Haematology training in the north central London deanery, with the majority of my training spent at University College Hospital. I am currently undertaking a split-site PhD through UCL and the University of Pennsylvania in Philadelphia. My PhD project is exploring the mechanisms of resistance in CAR-T therapy for acute myeloid leukaemia and is trying to determine why CAR-T outcomes in this group remain poor.  Skills I’ve developed during Covid include patience, resilience and cooking vegetable curry.

Martin L. Olsson received his M.D. in 1991 and Ph.D. in 1997 from Lund University in Sweden where he is currently a full Professor and Senior Consultant in Transfusion Medicine. He was a guest researcher at the International Blood Group Reference Laboratory in Bristol in 1996 and a Visiting Associate Professor at Harvard Medical School in 2003-2008. Olsson is currently Vice Dean of the Faculty of Medicine in Lund, as well as Medical Director of the Nordic Reference Laboratory there. His main clinical and research interest is the molecular genetics of blood groups and their functional roles in health and disease. His many awards include prestigious prizes from BBTS, ISBT, AABB and others. He served as the President of ISBT in 2018-2020.

Willem H Ouwehand is University of Cambridge Professor of Experimental Haematology, holds honorary appointments at Cambridge University Hospitals, NHS Blood and Transplant and the Welcome Sanger Institute and is a Fellow of the Academy of Medical Sciences. His recent research has been on rare diseases with a focus on inherited bleeding, platelet and thrombotic disorders. As a founder of the NIHR BioResource, Willem has coordinated the NIHR BioResource whole-genome sequencing study for Rare Diseases for the 100,000 Genomes Project.

In his long-standing collaboration with Professor Nicole Soranzo, he has worked with her on unravelling the genetic architecture of blood cell formation by performing genome-wide association studies for full blood cell count parameters in large-scale population studies, including the Donor Health Cohorts INTERVAL, COMPARE and now STRIDES.

In 2016 he founded with Dr Nick Gleadall the Blood transfusion Genomics Consortium, a collaborative on blood cell immunogenetics in 7 countries and across 4 continents. The Consortium brings together experts in immunogenetics, computer science and bioinformatics, statistical genomics, genotyping instrumentation & array design and regulatory matters from Blood Services, Academia and Industry. The aim of the consortium is to bring an affordable DNA test for high throughput blood cell antigen typing of donors and patients to the frontline of transfusion to support better matching in frequently transfused patients. 

He lives in Cambridge, is married to Sally with whom he has two daughters.

Professor Simon J. Stanworth is Consultant Haematologist for NHS Blood & Transplant at the John Radcliffe Hospital,  Oxford University Hospitals NHS Foundation Trust, and the University of Oxford. His research as a Principal Investigator in Clinical Research in transfusion medicine is centered on clinical indications of blood components and use of alternatives. He is Chair of the Specialty Working Group for Transfusion for the European Haematology Association, and deputy Chair for the International Committee Transfusion Medicine Guidelines (ICTMG). He is Secretary of the Regional Transfusion Committee for Oxford and Southampton/Hants.

Jenny has recently taken on the role of Executive Director at the International Society of Blood Transfusion (ISBT). She has a background in biomedical science and worked both in the NBS and as a hospital transfusion laboratory manager before specialising  EQA at UK NEQAS for more than 20 years. Jenny has been involved in developing BSH transfusion guidelines,  chaired the BBTS Professional Affairs and Education Committee and acted as a RCPath examiner for the FRCPath examination in Transfusion Science.

Heidi Doughty is a consultant in Transfusion Medicine working for NHS Blood and Transplant based in Birmingham, UK.  She qualified in medicine from Cambridge University in 1985 before undertaking higher training in internal medicine, haematology and management in Nottingham and London. She completed her doctoral thesis in military transfusion medicine in Bergen, Norway. 

She chairs the National Blood Transfusion Committee Emergency Planning working group and is president of the British Blood Transfusion Society. She is an honorary Senior Research Fellow at the University of Birmingham and is affiliated with Birmingham’s NIHR Surgical Reconstruction and Microbiology Research Centre.  Her current interests include the development and delivery of pre-hospital transfusion and emergency planning. 
 

Tom is a final year haematology speciality trainee in the Severn Deanery, working at the Royal United Hospital, Bath. He graduated from Imperial College, London in 2006 and has served as a Medical Officer in the Royal Navy since 2003. He has served on submarines, surface ships and land including deployment to Oman and Afghanistan. He sits on the Defence Medical Services Transfusion Committee and the NATO Blood Panel as Secretary. He has recently completed his MD studies investigating the effectiveness of Cold Stored Platelets in Cardiac Surgery, a collaboration he formed between the US Army Institute of Surgical Research, San Antonio, Texas and University of Bristol.